These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12594387)

  • 21. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
    Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI
    Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).
    Colleoni GW; Bridge JA; Garicochea B; Liu J; Filippa DA; Ladanyi M
    Am J Pathol; 2000 Mar; 156(3):781-9. PubMed ID: 10702393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory myofibroblastic tumor of the posterior mediastinum: an older adult case with anaplastic lymphoma kinase abnormalities determined using immunohistochemistry and fluorescence in situ hybridization.
    Makimoto Y; Nabeshima K; Iwasaki H; Ishiguro A; Miyoshi T; Shiraishi T; Iwasaki A; Shirakusa T
    Virchows Arch; 2005 Apr; 446(4):451-5. PubMed ID: 15778844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck: Highlighting a Novel Fusion and Potential Diagnostic Pitfall.
    Kerr DA; Thompson LDR; Tafe LJ; Jo VY; Neyaz A; Divakar P; Paydarfar JA; Pastel DA; Shirai K; John I; Seethala RR; Salgado CM; Deshpande V; Bridge JA; Kashofer K; Brčić I; Linos K
    Am J Surg Pathol; 2021 Dec; 45(12):1707-1719. PubMed ID: 34001695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors.
    Alassiri AH; Ali RH; Shen Y; Lum A; Strahlendorf C; Deyell R; Rassekh R; Sorensen PH; Laskin J; Marra M; Yip S; Lee CH; Ng TL
    Am J Surg Pathol; 2016 Aug; 40(8):1051-61. PubMed ID: 27259007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenic TPM3-ALK activation requires dimerization through the coiled-coil structure of TPM3.
    Amano Y; Ishikawa R; Sakatani T; Ichinose J; Sunohara M; Watanabe K; Kage H; Nakajima J; Nagase T; Ohishi N; Takai D
    Biochem Biophys Res Commun; 2015 Feb; 457(3):457-60. PubMed ID: 25596129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
    Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
    Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1.
    Haimes JD; Stewart CJR; Kudlow BA; Culver BP; Meng B; Koay E; Whitehouse A; Cope N; Lee JC; Ng T; McCluggage WG; Lee CH
    Am J Surg Pathol; 2017 Jun; 41(6):773-780. PubMed ID: 28490045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions.
    Acosta AM; Demicco EG; Dal Cin P; Hirsch MS; Fletcher CDM; Jo VY
    Mod Pathol; 2021 Feb; 34(2):469-477. PubMed ID: 32908253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.
    Lee JC; Li CF; Huang HY; Zhu MJ; Mariño-Enríquez A; Lee CT; Ou WB; Hornick JL; Fletcher JA
    J Pathol; 2017 Feb; 241(3):316-323. PubMed ID: 27874193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uterine inflammatory myofibroblastic tumor: First report of a ROS1 fusion.
    Bennett JA; Wang P; Wanjari P; Diaz L; Oliva E
    Genes Chromosomes Cancer; 2021 Dec; 60(12):822-826. PubMed ID: 34322931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anaplastic lymphoma kinase-positive pulmonary inflammatory myofibroblastic tumor with sarcomatous morphology and distant metastases: An unusual histomorphology and behavior.
    Sethi B; Pai T; Allam A; Epari S
    Indian J Pathol Microbiol; 2015; 58(4):509-12. PubMed ID: 26549078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases.
    Li XQ; Hisaoka M; Shi DR; Zhu XZ; Hashimoto H
    Hum Pathol; 2004 Jun; 35(6):711-21. PubMed ID: 15188137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions.
    Lovly CM; Gupta A; Lipson D; Otto G; Brennan T; Chung CT; Borinstein SC; Ross JS; Stephens PJ; Miller VA; Coffin CM
    Cancer Discov; 2014 Aug; 4(8):889-95. PubMed ID: 24875859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.
    Mossé YP; Voss SD; Lim MS; Rolland D; Minard CG; Fox E; Adamson P; Wilner K; Blaney SM; Weigel BJ
    J Clin Oncol; 2017 Oct; 35(28):3215-3221. PubMed ID: 28787259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor.
    Bridge JA; Kanamori M; Ma Z; Pickering D; Hill DA; Lydiatt W; Lui MY; Colleoni GW; Antonescu CR; Ladanyi M; Morris SW
    Am J Pathol; 2001 Aug; 159(2):411-5. PubMed ID: 11485898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanostring-based screening for tyrosine kinase fusions in inflammatory myofibroblastic tumors.
    Kurihara T; Suehara Y; Akaike K; Hayashi T; Kohsaka S; Ueno T; Hasegawa N; Takagi T; Sasa K; Okubo T; Kim Y; Mano H; Yao T; Kaneko K; Saito T
    Sci Rep; 2020 Oct; 10(1):18724. PubMed ID: 33127954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ALK-positive gastric inflammatory myofibroblastic tumor in an adult with familial adenomatous polyposis and diffuse fundic polyposis.
    Fan J; Huang B; Yang X; Yang M; He J; Nie X
    Diagn Pathol; 2017 Sep; 12(1):68. PubMed ID: 28923119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Presence of ALK Alterations and Clinical Relevance of Crizotinib Treatment in Pediatric Solid Tumors.
    Felkai L; Bánusz R; Kovalszky I; Sápi Z; Garami M; Papp G; Karászi K; Varga E; Csóka M
    Pathol Oncol Res; 2019 Jan; 25(1):217-224. PubMed ID: 29081033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
    Pittaluga S; Wlodarska I; Pulford K; Campo E; Morris SW; Van den Berghe H; De Wolf-Peeters C
    Am J Pathol; 1997 Aug; 151(2):343-51. PubMed ID: 9250148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.